Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

FuturHealth vs T2D.com

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

FuturHealth

Best for pending product verification
★★★3.6

Starting at $199/mo

CompoundedWeight Loss Medication
Visit FuturHealth
6.1

T2D.com

Best for diabetic GLP-1 access
★★★☆☆3.1

Starting at $999/mo

CompoundedSemaglutideTirzepatidePrescriber Included
Visit T2D.com

Side-by-Side Comparison

FeatureFuturHealthT2D.com
Overall Score7.1/106.1/10
Starting Price$199/mo$999/mo
Editorial Rating3.6 ★ /53.1 ★ /5
Features2 features7 features
States Available01
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

FuturHealth

Pros

  • Katalys-approved program at $180 default CPA — non-trivial commission
  • Explicitly positioned around weight loss medication (not a general telehealth catch-all)

Cons

  • Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
  • Confidence is LOW until that pass is done
  • Domain not yet verified — futurhealth.com may not be the correct landing page

T2D.com

Pros

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Cons

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Our Verdict

Winner: FuturHealthScore: 7.1/10

FuturHealth edges out T2D.com with a higher overall score of 7.1/10 and is particularly strong for pending product verification. T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.